Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 18, 2018
Blood Vessel Invasion Is a Strong Predictor of Postoperative Recurrence in Endometrial CancerMarie Sato, Ayumi Taguchi, Yamato Fukui, et al.
Prostate International|January 10, 2024
Prostate-specific antigen doubling time predicts the efficacy of site-directed therapy for oligoprogressive castration-resistant prostate cancerTaketo Kawai, Satoru Taguchi, Keina Nozaki, et al.
World Journal of Urology|November 30, 2017
Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancerAkihiko Matsumoto, Tohru Nakagawa, Atsushi Kanatani, et al.
Scientific Reports|March 31, 2024
Development of risk-score model in patients with negative surgical margin after robot-assisted radical prostatectomyYuta Yamada, Yoichi Fujii, Shigenori Kakutani, et al.
International Journal of Clinical Oncology|March 3, 2025
The first real-world evidence on dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin followed by switch maintenance avelumab in advanced urothelial carcinoma: a propensity score-matched studySatoru Taguchi, Taketo Kawai, Yoshiaki Kurokawa, et al.
Japanese Journal of Clinical Oncology|January 15, 2025
Optimization of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy for Japanese patients with urothelial carcinomaTaketo Kawai, Yoshiaki Kurokawa, Satoru Taguchi, et al.
Annals of Surgical Oncology|July 9, 2017
Oncologic Outcome of Metastasectomy for Urothelial Carcinoma: Who Is the Best Candidate?Tohru Nakagawa, Satoru Taguchi, Atsushi Kanatani, et al.
Japanese Journal of Clinical Oncology|June 27, 2025
Predictive ability of the geriatric 8 screening tool for treatment completion of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin therapy in patients with urothelial carcinomaYoshiaki Kurokawa, Taketo Kawai, Satoru Taguchi, et al.
World Journal of Urology|February 4, 2023
Subclassification of pT3 upper tract urothelial carcinoma: a multicenter retrospective studyYukio Yamada, Tohru Nakagawa, Jimpei Miyakawa, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 23, 2023
Enfortumab vedotin versus platinum rechallenge in post-platinum, post-pembrolizumab advanced urothelial carcinoma: A multicenter propensity score-matched studySatoru Taguchi, Taketo Kawai, Yoshiki Ambe, et al.
Pageof 14